FDA Grants Approval to First Maternal RSV Vaccine, Boosting Infant Protection
The Food and Drug Administration has approved the first maternal vaccine to help protect newborns against respiratory syncytial virus (RSV). The vaccine would be administered in late pregnancy to reduce the risk of severe RSV infection in newborns. However, the vaccine won’t immediately be available on pharmacy shelves for pregnant women. It is still awaiting […]
